Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia

HJF Salzer, G Schäfer, M Hoenigl, G Günther… - Respiration, 2018‏ - karger.com
The substantial decline in the Pneumocystis jirovecii pneumonia (PCP) incidence in HIV-
infected patients after the introduction of antiretroviral therapy (ART) in resource-rich settings …

[HTML][HTML] The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia

A Apostolopoulou, JA Fishman - Journal of Fungi, 2022‏ - mdpi.com
Pneumocystis jiroveci remains an important fungal pathogen in immunocompromised hosts.
The environmental reservoir remains unknown. Pneumonia (PJP) results from airborne …

Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses …

JP Donnelly, SC Chen, CA Kauffman… - Clinical Infectious …, 2020‏ - academic.oup.com
Abstract Background Invasive fungal diseases (IFDs) remain important causes of morbidity
and mortality. The consensus definitions of the Infectious Diseases Group of the European …

Coronavirus disease 2019–associated invasive fungal infection

JW Baddley, GR Thompson III… - Open forum …, 2021‏ - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

L Pagano, M Caira, A Candoni, M Offidani… - …, 2006‏ - haematologica.org
BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate the incidence and
outcome of invasive fungal infections (IFI) in patients with hematologic malignancies …

Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus

K Lagrou, S Chen, H Masur, C Viscoli… - Clinical Infectious …, 2021‏ - academic.oup.com
Background Pneumocystis jirovecii pneumonia (PCP) causes substantive morbidity in
immunocompromised patients. The EORTC/MSGERC convened an expert group to …

ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

G Maschmeyer, J Helweg-Larsen… - Journal of …, 2016‏ - academic.oup.com
The initiation of systemic antimicrobial treatment of Pneumocystis jirovecii pneumonia (PCP)
is triggered by clinical signs and symptoms, typical radiological and occasionally laboratory …

Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies …

L Cooley, C Dendle, J Wolf, BW Teh… - Internal medicine …, 2014‏ - Wiley Online Library
P neumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with
cancer‐related immunosuppression. There are well‐defined patients who are at risk of PJP …

Cavitary pulmonary disease

LB Gadkowski, JE Stout - Clinical microbiology reviews, 2008‏ - journals.asm.org
SUMMARY A pulmonary cavity is a gas-filled area of the lung in the center of a nodule or
area of consolidation and may be clinically observed by use of plain chest radiography or …

The impact of corticosteroids on the outcome of fungal disease: a systematic review and meta-analysis

Z Li, DW Denning - Current Fungal Infection Reports, 2023‏ - Springer
Abstract Purpose of Review Corticosteroids have a complex relationship with fungal disease—
risk for many, benefit for others. This systematic review aims to address the effect of …